Eli Lilly & Co (LLY) - Animal Health Revenue (DISCONTINUED) (I:ELCLLYAH)
Level Chart
Basic Info
Eli Lilly & Co (LLY) - Animal Health Revenue is at a current level of 0.000, unchanged from 0.00 one year ago. This is a change of N/A from one year ago. |
Animal Health Revenue refers to the total revenue generated by Eli Lilly & Co from its animal health division within a specific reporting period. |
Report | FinChat.io |
Category | Segments & KPIs |
Region | United States |
Source | FinChat.io |
Data provided via FinChat.io |
Stats
Last Value | 0.00 |
Latest Period | 2022 |
Last Updated | Jul 27 2023, 09:47 EDT |
Average Growth Rate | -10.09% |
Value from 1 Year Ago | 0.00 |
Change from 1 Year Ago | N/A |
Frequency | Yearly |
Unit | USD |
Adjustment | N/A |
Historical Data
Date | Value |
---|---|
December 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
Date | Value |
---|---|
December 31, 2016 | 3.158B |
December 31, 2015 | 3.181B |
December 31, 2014 | 2.347B |
December 31, 2013 | 2.152B |
December 31, 2012 | 2.036B |
News
Headline
Wire
Time (ET)
Globe Newswire
11/21 08:00
Globe Newswire
11/19 10:10
MT Newswires
11/15 15:02
Accesswire
11/15 12:05
Accesswire
11/12 13:00
PR Newswire
11/12 08:00
PR Newswire
11/12 07:30
PR Newswire
11/05 05:00
Basic Info
Eli Lilly & Co (LLY) - Animal Health Revenue is at a current level of 0.000, unchanged from 0.00 one year ago. This is a change of N/A from one year ago. |
Animal Health Revenue refers to the total revenue generated by Eli Lilly & Co from its animal health division within a specific reporting period. |
Report | FinChat.io |
Category | Segments & KPIs |
Region | United States |
Source | FinChat.io |
Data provided via FinChat.io |
Stats
Last Value | 0.00 |
Latest Period | 2022 |
Last Updated | Jul 27 2023, 09:47 EDT |
Average Growth Rate | -10.09% |
Value from 1 Year Ago | 0.00 |
Change from 1 Year Ago | N/A |
Frequency | Yearly |
Unit | USD |
Adjustment | N/A |
Related Securities
Related Indicators
Eli Lilly & Co (LLY) - Cardiovascular Revenue (DISCONTINUED) | 0.00 USD |
Eli Lilly & Co (LLY) - Diabetes Revenue | 19.67B USD |
Eli Lilly & Co (LLY) - Diabetes Revenue | 7.515B USD |
Eli Lilly & Co (LLY) - Endocrinology Revenue (DISCONTINUED) | 0.00 USD |
Eli Lilly & Co (LLY) - Immunology Revenue | 3.798B USD |
Eli Lilly & Co (LLY) - Immunology Revenue | 339.50M USD |
Eli Lilly & Co (LLY) - Neuroscience Revenue | 2.878B USD |
Eli Lilly & Co (LLY) - Neuroscience Revenue | 2.159B USD |
Eli Lilly & Co (LLY) - Oncology Revenue | 6.658B USD |